The overexpression of Mettl3 improved the co-cultured AML cells’ sensitivity to chemotherapy, whereas the knockdown of Mettl3 resulted in chemoresistance compared to sensitivity in the controls (Fig. 4G, H). This evidence concerns the gene METTL3 and acute myeloid leukemia.